1.Observation on the efficacy of nedaplatin combined with 5-fluorouracil in treatment of advanced esophageal cancer
Chinese Journal of Primary Medicine and Pharmacy 2011;18(12):1641-1643
Objective To compare the efficacy of nedaplatin(NDP) and cisplatin( DDP) combined with 5-fluorouracil(S-Fu) in treatment of advanced esophageal cancer.Methods 61 patients with advanced esophageal cancer were divided into two groups randomly,the observation group(NDP group) were 30 cases and the control group (DDP group) were 31 cases.NDP group were given NDP(80 ~ 100mg/m2, intravenous drip, 1 day) and 5-Fu (0.5g/m2,intravenous drip,l~5 day) ,DDP group were given DDP(80 ~100mg/m2 ,devided into 3 days) and5-Fu ( 0.5 g/m2 , intravenous drip ,1~5 day).The cycles were repeated every 4 weeks, and the effects were assessed after 2 cycles.Results The remisson rate of the observation group was 56.1% ,significantly higher than that of the control group (29.0% ) ( P <0.05).The toxicity of the observation group was milder for gastrointestinal tract but more serious for bone marrow than that of the control group (all P < 0.05).Conclusion NDP was an effective platinum drug for esophageal carcinoma.The efficacy of nedaplatin combined with 5-Fu regimen was better than that of DDP combined with 5-Fu regimen,and it had a good clinical tolerance and could be recommended as the first-line drugs.
2.Clinical analysis of interventional therapy in 27 patients with intraeranial aneurysm
Yuan LIU ; Yongling LIU ; Li ZHANG
Chinese Journal of Primary Medicine and Pharmacy 2009;16(12):2143-2144
Objective To evaluate the interventional aneurysm embolization treatment of clinical experience.Method Retrospective analysis of 27 cases with intracranial aneurysm embolization patients data,including their incidence,embolization treatment and prognosis.Result 27 cases of aneurysm embolization follow-up for 3~12 months,no case of rebleeding.24 cases were good recovery,1 case limb paralysis,1 case died,1 patient is not followed up.Conelusion The efficacy of embolization in the treatment of intracranial aneurysms is significant.
3.Clinicopathologic analysis of cerebral hemisphere ulegyria in 26 patients with refractory epilepsy
Yan LI ; Yunlin LI ; Yongling LIU
Chinese Journal of Applied Clinical Pediatrics 2017;32(10):784-787
Objective To investigate the clinicopathologic features of cerebral hemisphere ulegyria in children with refractory epilepsy.Methods The clinical and pathologic findings were reviewed in 26 children who underwent resection of lesion and epileptogenic lobectomy operation in the Neurosurgery Department of Haidian Hospital,Haidian District of Peking University Third Hospital,from January 2011 to August 2015,and pathological diagnosis was cerebral hemisphere ulegyria.Results All children including 19 male and 7 female had medically intractable seizures.The mean ages of seizure onset and disease duration were 3.93 years old (from 10 days to 12 years old) and 5.42 years (from 1 month to 13 years),respectively.Eight cases had seizures because of perinatal period injury,and 12 cases developed seizures owing to infancy injury and others had no cause of disease.The mean operation age was 9.35 years old (5-14 years old).Fourteen cases underwent multilobar resection and the whole corpus callosum incision,and 12 cases were given modified anatomical cerebral hemisphere resection.The pathological diagnoses of brain tissues were cerebral hemisphere ulegyria with focal cortical dysplasia(FCD) Ⅲ d and dual pathology.Seizure outcome after the operation revealed that 19 cases (73.08%) had an Engel grade Ⅰ,3 cases (11.54%)had an Engel grade Ⅱ,2 cases (7.69%) had an Engel grade Ⅲ,and 2 cases (7.69%) missed the follow-up.Conclusions Acquired brain injury during the period of infant can cause ulegyria and cortical dysplasia,resulting in intractable epilepsy.The treatment of improved anatomical cerebral hemisphere resection and multilobar resection is significantly effective.
4.Research Advances and Prospects of Acupuncture in Treating Childhood Cerebral Palsy
Jing HE ; Changqiong HUANG ; Yongling ZHANG ; Yi LIU ; Yuanchun XIAO
Journal of Acupuncture and Tuina Science 2005;3(4):58-62
This paper analyzes and discusses the research advances of acupuncture in the treatment of childhood cerebral palsy from the perspectives of clinical treatment and its mechanism. Acupuncture has great advantages in the treatment of childhood cerebral palsy,however, there are methodological problems in current researches, clinical researches in particular. High-quality clinical researches should be conducted to improve clinical efficacy fully.
5.Optimization of Dry Granulation Technology for Yinqiao Baidu Tablet by Orthogonal Test
Yongling LIU ; Jie SHAO ; Yongxiang WANG ; Qingfen ZHANG ; Zhenzhong WANG
China Pharmacy 2017;28(25):3553-3556
OBJECTIVE:To optimize the dry granulation technology conditions for Yinqiao baidu tablet. METHODS:Using granulating difficulty degree and disintegration time as investigation indexes,ratio and amount of accessories microcrystalline cellu-lose and compressible starch in Yinqiao baidu tablet,moisture content of the sprayed powder were screened. Using yield of particle and angle of repose as indexes,L9(34)orthogonal test was used to optimize the wheel pressure,rotating speed and feeding speed in dry granulation technology,and verification test was conducted. RESULTS:The ratio of microcrystalline cellulose and compress-ible starch was 7:3,and mixing ratio of the two with spray powder+inclusion compound was 1:5. The moisture content of spray powder was controlled in 1%-2%. The optimal technology was as follow as wheel pressure of 3.5 MPa,roller speed of 4 r/min and feeding speed of 10 r/min. In verification test,average yield of particle was 69.2% and angle of repose was 31.5 °. Transfer rate of chlorogenic acid had reached over 92%,and RSD of each index was below 2.53%(n=3). CONCLUSIONS:Each index of parti-cle prepared by optimized accessories formulation and technology shows good reproducibility and feasibility,and the technology is stable and suitable for production.
6.Clinical study of gemcitabine plus cisplatin combined with in the treatment of advanced non-Small cell lung cancer
Yongling LIU ; Zhongmin WANG ; Keliang LU ; Yong ZHU ; Nansheng YU ; Jiyue WAN
Chinese Journal of Primary Medicine and Pharmacy 2010;17(4):445-446
Objective To investigate the efficacy and toxicities of gemcitabine and cisplatin as a chemother-apy regimen for patients with advanced non-small cell lung cancer (NSCLC). Methods Thirty-five patients with NSCLC were enrolled in this study. C, emeitabine was given on day 1 and 8 at a dose of 1000 mg/m~2 and cisplatin at a dose of 25 mg/m~2 on day 1 to 3. The chemotherapy was repeated every 28 days, after 2 cycles for evaluating response. Results Complete response (CR), partial response (PR) ,stable disease (SD) and progressive disease (PD) were observed in 0,14,16 and 5 cases, respectively, with a response rate (RR) of 40. 0%. The RR in initial treatment group was found more than that in the retreatment group (52. 2% vs 16.7% ,P<0. 05).The main toxicities were tol-erable, which included myelosuppression, nausea, vomiting, and liver damage. Conclusion Gemcitabine combined with cisplatin is effective and safe in the treatment of NSCLC, especially in the initial treatment patients.
7.Prognosis analysis of esophageal carcinoma patients with tumor loco-regional recurrence after curative surgery
Xiaojiang SUN ; Yaping XU ; Yongling JI ; Jinshi LIU ; Youhua JIANG ; Shenglin MA ; Weimin MAO
Chinese Journal of Radiological Medicine and Protection 2010;30(3):333-335
Objective To evaluate the outcome of radiotherapy for recurrent esophageal cancer after surgery and to determine the prognostic factors. Methods From Jan 2004 to Dec 2009, 93 patients of esophageal carcinoma with loco-regional recurrence as the first site of failure after surgery were retrospectively reviewed. Kaplan-Meier method was used to analyze the survival. Logrank test was used to evaluate the difference between the groups. Multivariate survival analysis was conducted using a Cox proportional hazard regression model with a backward stepwise procedure. Results The overall survival rates at 1, 2 and 3 years were 40. 9% , 10. 1% and 6. 7% ,respectively,but with a median survival time of 11.0 months(95% CI 9. 4-12. 6) . In univariate analysis, age,PS, radiation dose and retreatment methods were independent prognostic factors. In multivariate analysis, only radiation dose and retreatment methods were independent prognostic factors for overall survival. Conclusions The prognosis of patients with postoperative loco-regional recurrence of esophageal cancer is poor. However, a long-term survival maybe expected by definitive chemoradiotherapy.
8.Survey on changes of breast cancer radiotherapy in four hospitals within southeast coastal region of China
Yongling JI ; Jingjie LIU ; Ye TIAN ; Xianming LI ; Yaqun ZHU ; De YU ; Xianghui DU
Chinese Journal of Radiological Medicine and Protection 2010;30(3):307-309
Objective To explore the changes and the tendency of breast cancer radiotherapy in China within the past decade.Methods A survey on breast cancer radiotherapy in 1 999 and 2006 was conducted in 4 hospitals located within the southeast coastal region of China,including patients'clinical characteristics,the purpose of radiotherapy and its techniques.Results The percentage of breast conservative treatment(BCT)increased from 3%in 1999 to 13%in 2006.For radiotherapy techniques in 2006 compared with 1999,the growth trend was found in use of breast immobilization devices(80% vs.46%),treatment planning system(70% vs.23%),and CT simulation(14%vs.0).The frequency was increased in the chest wall irradiation after masteetomy(90%vs.67%),but decreased in internal mammary region(30%vs.76%)and axilla(37%vs.69%)treatment.There were no differences in total dose and fractionation prescription.Conclusions BCT was performed more frequently,but postmastectomy radiotherapy was still essential option in China at present.Although some advanced techniques were applied frequently in clinical practice.Simulation,treatment planning,and irradiation target design were urgent for improvement and standardization.
9.Relationship between adiponectin and the first phase of glucose-stimulated insulin secretion from pancreatic β-cell in patients with type 2 diabetes mellitus
Dengyou QIN ; Huacong DENG ; Yanqin AI ; Ming GONG ; Qiang LIU ; Yongling LI ; Gongpu MI
Chinese Journal of Endocrinology and Metabolism 2010;26(7):564-567
Objective To investigate the relationship between adiponectin and the first-phase of pancreatic P-cell insulin secretion in subjects with different statuses of glucose tolerance. Methods Thirty-seven patients with newly diagnosed type 2 diabetes mellitus (DM) , 30 patients with abnormal glucose tolerance (IGR) , and 40 normal control subjects (NGT) underwent intravenous glucose tolerance test (IVGTT). Fasting adiponectin and proinsulin (PI) was assayed by EL1SA. Fasting free fatty acid ( FFA) was measured by colorimetry. Insulin area under the curve ( AUC ) , incremental AUC (iAUC) from 0 min to 10 min, AIR3-5, homeostasis model assessment for insnlin resistance (HOMA-IR) , and for β cell function ( HOMA-p) were calculated. The relationship between adiponectin and AUC, iAUC, AIR3-5, proinsulin, FFA, and HOMA-IR was explored. Results (1) The levels of AUC, iAUC, AIR3-5, and adiponectin in DM group and IGR group were significantly lower than those in NGT group (P<0.05), reduced in DM group than those in IGR group(P<0.05). (2) The levels of PI in DM group and IGR group were significantly higher than that in NGT (P<0.05). (3) Adiponectin was positively correlated with HOMA-p,AUC,iAUC,AIR3-5, and HDL-C,while negatively correlated with proinsulin, HOMA-IR, and LDL-C. (4) Proinsulin was positively correlated with HOMA-IR. (5 ) Multiple regression stepwise analysis showed that adiponectin was independently associated with AUC. Conclusions Adiponectin was an independent factor affecting the first phase of pancreatic p-cell insulin secretion. Low adiponectin level could predict the dysfunction of the first phase pancreatic p-cell secretion as well as insulin resistance in patients with type 2 diabetes.
10.Preliminary study of the lethal effects of E. coli DNA on mice
Wendong PAN ; Hong ZHOU ; Jiang ZHENG ; Peiyuan XIA ; Xiaojian QIN ; Yongling LU ; Xiaolu LIU
Journal of Third Military Medical University 2001;23(4):395-397
Objective To investigate the role of bacterial DNA in systemic inflammatory response syndrome (SIRS). Methods A total of 100 mice of Kunming species were divided into ten groups: E.coli DNA (30, 20, 10, 5 and 1 mg/kg ), 30 mg/kg of CT DNA, 60Co DNA, DNased DNA, organic residue of DNA extraction and sterile water control. The last two were pre-treated with D-galactoamine (600 mg/kg intra peritoneally). Animals were administratively injected via tail vein. General physical condition and the death rate of mice were observed within 48 h. Results ①Obvious lethal effect of double strand E.coli DNA on mice were observed with a dose-effect correlation, LD50=11.51 mg/kg. ②NO difference in death rate was found in the group of 30 mg/kg E.coli DNA with or without 60Co irradiation (10/10 and 8/10,P>0.05). ③No rats died in the group of DNased DNA, organic residue of DNA extraction and calf thymic DNA (0/10). Conclusion Bacterial DNA may play an important role in the development of SIRS.